An indictment was returned today by a federal grand jury in New Jersey, charging the former chief executive officer of a publicly-traded health care company (referred to in the indictment as Company-1) with two counts of securities fraud for his alleged participation in a scheme to mislead investors about Company-1’s procurement of COVID-19 rapid test kits in the early days of the COVID-19 pandemic.
from Justice News https://ift.tt/XkZps25
Get free legal consulting with complete case evaluation by a senior professional Attorney with us. Click Beaty Law Firm to explore more.
No comments:
Post a Comment